Diagnostic Specialty Enzymes Market

Diagnostic Specialty Enzymes Market (Product: Proteases, Carbohydrases, Polymerases & Nucleases, Oxidases, and Others; and Application: Clinical Chemistry, Molecular Diagnostics, Immunoassay, and Others) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast, 2023-2031

Diagnostic Specialty Enzymes Market Outlook 2031

  • The global industry was valued at US$ 1.0 Bn in 2022
  • It is estimated to grow at a CAGR of 6.9% from 2023 to 2031 and reach US$ US$ 1.8 Bn by the end of 2031

Analyst Viewpoint

Increase in demand for non-toxic biological catalysts in diagnostics and pharmaceutical industries is positively influencing the global diagnostic specialty enzymes market value. Enhancements in tools intended to optimize production in the pharmaceutical sector are boosting the adoption of specialty enzymes.

Surge in awareness regarding the multi-functional benefits of specialty enzymes and innovations in terms of technologies aimed at reducing the consumption of chemically produced catalysts are fueling the diagnostic specialty enzymes market size.

Players operating in the global specialty enzymes industry are engaged in various corporate development and expansion strategies, such as mergers and acquisitions, portfolio expansion, and new product launches, to amass a lucrative industry position.

Market Introduction

Enzymes are natural biocatalysts, produced and harvested from living organisms such as plants, animals, bacteria, and fungi. Diagnostic specialty enzymes are used in low-volume and high-value-added applications. Applications of diagnostic specialty enzymes include clinical chemistry, molecular diagnostics, and immunoassay.

Solutions in the diagnostic specialty enzymes market landscape are used in processing applications of DNA and RNA polymers such as replication, recombination, transcription, and repair. Proteases, polymerases, lipases, nucleases, and carbohydrase, including cellulases and amylases, are various types of specialty enzymes. These products can be sourced from three primary sources, namely, plants, microorganisms, and animals.

Increase in Demand for Non-toxic Biological Catalysts Fueling Diagnostic Specialty Enzymes Market Revenue

Biocatalysts have been considered to be low-toxic and eco-friendly catalysts that reveal site- and enantioselectivity for specific substrates in various transformations. These catalysts place substrates in ideal positions to each other. This facilitates precise control of the reaction resulting in high chemo- and stereoselectivity.

Biocatalysts offer properties such as low toxicity, biodegradability, excellent selectivity, and good catalytic performance under mild reaction conditions. Thus, they are often regarded as green catalysts compared to conventional chemical catalysts in organic synthesis.

Nucleases and polymerases are widely employed in a variety of end-use industry verticals such as research, diagnostics, biocatalysts, biotechnology, and pharmaceuticals. Nucleases are used in molecular biology research to fragment DNA or RNA for various experiments including gene cloning, sequencing, and mapping.

Hence, rise in investment in molecular biology is augmenting the diagnostic specialty enzymes market share. In June 2023, Merck announced plans to create nearly 500 jobs in Scotland as part of a £30 Mn investment in two drug testing sites. The investment includes a new 1,200 sq m facility in Glasgow, which will house molecular biology and sequencing services.

Rise in Prevalence of Diseases Driving Market Progress

Specialty enzymes play a crucial role in various diagnostic assays and tests. They are employed in the diagnosis of various diseases such as cancer, cardiovascular diseases, and infectious diseases.

In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths were projected to occur in the U.S., according to the National Institutes of Health. Several studies are proposing potential inhibitors targeting various enzymes to prevent cancer cell growth and proliferation.

Surge in investment in drug manufacturing and disease diagnostics is expected to spur the specialty enzymes market growth during the forecast period. In October 2023, Imeka announced an investment from the Alzheimer’s Drug Discovery Foundation (ADDF) to accelerate the development of novel biomarkers for Alzheimer's disease and related dementias.

The investment will support the use of Imeka neuroimaging biomarkers in a large-scale, longitudinal study of dementia markers and their progression from pre-symptomatic stages to the onset of Alzheimer’s disease and other types of dementia.

Specialty enzymes are employed in various diagnostic applications such as DNA manipulation and sequencing. A decline in the cost of DNA manipulation and sequencing is projected to drive demand and increase the usage of enzymes in biotechnology and diagnostic applications. Increase in geriatric population is augmenting the diagnostic specialty enzymes market development.

The demand for specialty enzymes used in diagnostic applications is likely to rise as the global population ages.According to the latest diagnostic specialty enzymes market trends, diagnostic and research & biotechnology enzymes are projected to gain traction due to advancements in molecular diagnostics.

Another trend is the use of diagnostic specialty enzymes in precision medicine for the identification of genetic variations associated with diseases.

Rise in personalized medicine is also driving the demand for diagnostic and research & biotechnology enzymes. Large pharmaceutical companies are heavily investing in the R&D of new drugs, thereby propelling the diagnostic specialty enzymes market demand.

High Demand for Polymerases & Nucleases

According to the latest diagnostic specialty enzymes market analysis, the polymerases & nucleases product segment held the largest share in 2022. Rise in usage of polymerise and nuclease enzymes in advanced biotech applications, such as DNA sequencing and DNA amplification, is fueling the segment.

The oxidases segment is likely to lose diagnostic specialty enzymes market share during the forecast period. In terms of application, the clinical chemistry segment is expected to continue to dominate the market from 2023 to 2031. Blood glucose monitoring was the leading sub-segment of the clinical chemistry segment in 2022 and is likely to account for major share during the forecast period.

Regional Outlook

North America accounted for the largest share in 2022. Increase in adoption of new biotechnology approaches, such as next-generation sequencing, and rise in investment in drug discovery are fueling the diagnostic specialty enzymes market dynamics of the region. Development of health care infrastructure, rise in population, growth in biotechnology sector, and increase in the burden of diseases are propelling the market trajectory in Asia Pacific.

Analysis of Key Players

F. Hoffmann-La Roche Ltd., Novozymes A/S, Codexis, Inc., BBI Solutions, Biocatalysts Ltd., Advanced Enzymes Technologies Ltd., American Laboratories, Inc., Thermo Fisher Scientific Inc., Amano Enzyme Inc., and Amicogen are key players operating in the global diagnostic specialty enzymes industry.

Major players, such as Codexis, Inc., Amano Enzymes, Inc., Biocatalysts Ltd., and Advanced Enzymes Technologies Ltd., have a strong presence in the global market. In the past few years, the market has witnessed high investments by various multinational enzyme manufacturers such as F. Hoffmann-La Roche Ltd., Novozymes, Codexis, and Biocatalysts.

Each of these companies has been profiled in the diagnostic specialty enzymes market report based on parameters such as company overview, business strategies, financial overview, business segments, product portfolio, and recent developments.

Key Developments

  • In January 2024, Novozymes and Chr. Hansen merged to form Novonesis, a world-leading biosolutions partner for better business, healthier lives, and a healthier planet
  • In 2022, Ginkgo Bioworks launched Ginkgo Enzyme Services, powered by ultra-high throughput screening and machine learning-guided protein design. Ginkgo Enzyme Services solves challenges for R&D teams developing enzymes, from the discovery of novel enzyme activity through optimization of enzyme function and large-scale manufacturing.

Diagnostic Specialty Enzymes Market Snapshot

Attribute Detail
Market Size in 2022 US$ 1.0 Bn
Market Forecast (Value) in 2031 US$ 1.8 Bn
Growth Rate (CAGR) 6.9%
Forecast Period 2023-2031
Quantitative Units US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Product
    • Proteases
    • Carbohydrases
    • Polymerases & Nucleases
    • Oxidases
    • Others
  • Application
    • Clinical Chemistry
      • POC Testing
      • Blood Glucose Monitoring
      • Others
    • Molecular Diagnostics
    • Immunoassay
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • Spain
  • Italy
  • France
  • U.K.
  • China
  • Japan
  • India
  • Australia and New Zealand
  • Japan
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa
Companies Profiled
  • F. Hoffmann-La Roche Ltd.
  • Novozymes A/S
  • Codexis, Inc.
  • BBI Solutions
  • Biocatalysts Ltd.
  • Advanced Enzymes Technologies Ltd.
  • American Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Amano Enzyme Inc.
  • Amicogen
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global diagnostic specialty enzymes market in 2022?

It was valued at US$ 1.0 Bn in 2022

How is the diagnostic specialty enzymes industry expected to grow during the forecast period?

It is anticipated to grow at a CAGR of 6.9% from 2023 to 2031

What are the key factors driving the demand for diagnostic specialty enzymes?

Increase in demand for non-toxic biological catalysts and rise in prevalence of diseases

Which diagnostic specialty enzymes product segment held the largest share in 2022?

The polymerases & nucleases segment held the largest share in 2022

Which was the major region in the global diagnostic specialty enzymes landscape in 2022?

North America was the leading region in 2022

Who are the prominent diagnostic specialty enzyme manufacturers?

F. Hoffmann-La Roche Ltd., Novozymes A/S, Codexis, Inc., BBI Solutions, Biocatalysts Ltd., Advanced Enzymes Technologies Ltd., American Laboratories, Inc., Thermo Fisher Scientific Inc., Amano Enzyme Inc., and Amicogen

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Diagnostic Specialty Enzymes Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution/Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Diagnostic Specialty Enzymes Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Product/Brand Analysis

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemic Impact on Industry

6. Global Diagnostic Specialty Enzymes Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Product, 2017–2031

        6.3.1. Proteases

        6.3.2. Carbohydrases

        6.3.3. Polymerases & Nucleases

        6.3.4. Oxidases

        6.3.5. Others

    6.4. Market Attractiveness Analysis, by Product

7. Global Diagnostic Specialty Enzymes Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Application, 2017–2031

        7.3.1. Clinical Chemistry

            7.3.1.1. POC Testing

            7.3.1.2. Blood Glucose Monitoring

            7.3.1.3. Others

        7.3.2. Molecular Diagnostics

        7.3.3. Immunoassay

        7.3.4. Others

    7.4. Market Attractiveness Analysis, by Application

8. Global Diagnostic Specialty Enzymes Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region, 2017–2031

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, by Region

9. North America Diagnostic Specialty Enzymes Market Analysis and Forecast

    9.1. Introduction

    9.2. Key Findings

    9.3. Market Value Forecast, by Product, 2017–2031

        9.3.1. Proteases

        9.3.2. Carbohydrases

        9.3.3. Polymerases & Nucleases

        9.3.4. Oxidases

        9.3.5. Others

    9.4. Market Value Forecast, by Application, 2017–2031

        9.4.1. Clinical Chemistry

            9.4.1.1. POC Testing

            9.4.1.2. Blood Glucose Monitoring

            9.4.1.3. Others

        9.4.2. Molecular Diagnostics

        9.4.3. Immunoassay

        9.4.4. Others

    9.5. Market Value Forecast, by Country, 2017–2031

        9.5.1. U.S.

        9.5.2. Canada

    9.6. Market Attractiveness Analysis

        9.6.1. By Product

        9.6.2. By Application

        9.6.3. By Country

10. Europe Diagnostic Specialty Enzymes Market Analysis and Forecast

    10.1. Introduction

    10.2. Key Findings

    10.3. Market Value Forecast, by Product, 2017–2031

        10.3.1. Proteases

        10.3.2. Carbohydrases

        10.3.3. Polymerases & Nucleases

        10.3.4. Oxidases

        10.3.5. Others

    10.4. Market Value Forecast, by Application, 2017–2031

        10.4.1. Clinical Chemistry

            10.4.1.1. POC Testing

            10.4.1.2. Blood Glucose Monitoring

            10.4.1.3. Others

        10.4.2. Molecular Diagnostics

        10.4.3. Immunoassay

        10.4.4. Others

    10.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        10.5.1. Germany

        10.5.2. U.K.

        10.5.3. France

        10.5.4. Italy

        10.5.5. Spain

        10.5.6. Rest of Europe

    10.6. Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Application

        10.6.3. By Country/Sub-region

11. Asia Pacific Diagnostic Specialty Enzymes Market Analysis and Forecast

    11.1. Introduction

    11.2. Key Findings

    11.3. Market Value Forecast, by Product, 2017–2031

        11.3.1. Proteases

        11.3.2. Carbohydrases

        11.3.3. Polymerases & Nucleases

        11.3.4. Oxidases

        11.3.5. Others

    11.4. Market Value Forecast, by Application, 2017–2031

        11.4.1. Clinical Chemistry

            11.4.1.1. POC Testing

            11.4.1.2. Blood Glucose Monitoring

            11.4.1.3. Others

        11.4.2. Molecular Diagnostics

        11.4.3. Immunoassay

        11.4.4. Others

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. China

        11.5.2. Japan

        11.5.3. India

        11.5.4. Australia & New Zealand

        11.5.5. Rest of Asia Pacific

    11.6. Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By Application

        11.6.3. By Country/Sub-region

12. Latin America Diagnostic Specialty Enzymes Market Analysis and Forecast

    12.1. Introduction

    12.2. Key Findings

    12.3. Market Value Forecast, by Product, 2017–2031

        12.3.1. Proteases

        12.3.2. Carbohydrases

        12.3.3. Polymerases & Nucleases

        12.3.4. Oxidases

        12.3.5. Others

    12.4. Market Value Forecast, by Application, 2017–2031

        12.4.1. Clinical Chemistry

            12.4.1.1. POC Testing

            12.4.1.2. Blood Glucose Monitoring

            12.4.1.3. Others

        12.4.2. Molecular Diagnostics

        12.4.3. Immunoassay

        12.4.4. Others

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. Brazil

        12.5.2. Mexico

        12.5.3. Rest of Latin America

    12.6. Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Application

        12.6.3. By Country/Sub-region

13. Middle East & Africa Diagnostic Specialty Enzymes Market Analysis and Forecast

    13.1. Introduction

    13.2. Key Findings

    13.3. Market Value Forecast, by Product, 2017–2031

        13.3.1. Proteases

        13.3.2. Carbohydrases

        13.3.3. Polymerases & Nucleases

        13.3.4. Oxidases

        13.3.5. Others

    13.4. Market Value Forecast, by Application, 2017–2031

        13.4.1. Clinical Chemistry

            13.4.1.1. POC Testing

            13.4.1.2. Blood Glucose Monitoring

            13.4.1.3. Others

        13.4.2. Molecular Diagnostics

        13.4.3. Immunoassay

        13.4.4. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. GCC Countries

        13.5.2. South Africa

        13.5.3. Rest of Middle East & Africa

    13.6. Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Application

        13.6.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

    14.2. Market Share Analysis, by Company (2022)

    14.3. Company Profiles

        14.3.1. F. Hoffmann-La Roche Ltd.

            14.3.1.1. Company Overview

            14.3.1.2. Product Portfolio

            14.3.1.3. SWOT Analysis

            14.3.1.4. Financial Overview

            14.3.1.5. Strategic Overview

        14.3.2. Novozymes A/S

            14.3.2.1. Company Overview

            14.3.2.2. Product Portfolio

            14.3.2.3. SWOT Analysis

            14.3.2.4. Financial Overview

            14.3.2.5. Strategic Overview

        14.3.3. Codexis, Inc.

            14.3.3.1. Company Overview

            14.3.3.2. Product Portfolio

            14.3.3.3. SWOT Analysis

            14.3.3.4. Financial Overview

            14.3.3.5. Strategic Overview

        14.3.4. BBI Solutions

            14.3.4.1. Company Overview

            14.3.4.2. Product Portfolio

            14.3.4.3. SWOT Analysis

            14.3.4.4. Financial Overview

            14.3.4.5. Strategic Overview

        14.3.5. Biocatalysts Ltd.

            14.3.5.1. Company Overview

            14.3.5.2. Product Portfolio

            14.3.5.3. SWOT Analysis

            14.3.5.4. Financial Overview

            14.3.5.5. Strategic Overview

        14.3.6. Advanced Enzymes Technologies Ltd.

            14.3.6.1. Company Overview

            14.3.6.2. Product Portfolio

            14.3.6.3. SWOT Analysis

            14.3.6.4. Financial Overview

            14.3.6.5. Strategic Overview

        14.3.7. American Laboratories, Inc.

            14.3.7.1. Company Overview

            14.3.7.2. Product Portfolio

            14.3.7.3. SWOT Analysis

            14.3.7.4. Financial Overview

            14.3.7.5. Strategic Overview

        14.3.8. Thermo Fisher Scientific Inc.

            14.3.8.1. Company Overview

            14.3.8.2. Product Portfolio

            14.3.8.3. SWOT Analysis

            14.3.8.4. Financial Overview

            14.3.8.5. Strategic Overview

        14.3.9. Amano Enzyme Inc.

            14.3.9.1. Company Overview

            14.3.9.2. Product Portfolio

            14.3.9.3. SWOT Analysis

            14.3.9.4. Financial Overview

            14.3.9.5. Strategic Overview

        14.3.10. Amicogen

            14.3.10.1. Company Overview

            14.3.10.2. Product Portfolio

            14.3.10.3. SWOT Analysis

            14.3.10.4. Financial Overview

            14.3.10.5. Strategic Overview

List of Tables

Table 01: Global Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 03: Global Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 04: North America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 05: North America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 06: North America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 07: Europe Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 08: Europe Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 09: Europe Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 10: Asia Pacific Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 11: Asia Pacific Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 12: Asia Pacific Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 13: Latin America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Latin America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 15: Latin America Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 16: Middle East & Africa Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Middle East & Africa Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Product, 2017–2031

Table 18: Middle East & Africa Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast, by Application, 2017–2031

List of Figures

Figure 01: Global Diagnostic Specialty Enzymes Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031

Figure 02: Global Diagnostic Specialty Enzymes Market Revenue (US$ Mn), by Product, 2022

Figure 03: Global Diagnostic Specialty Enzymes Market Value Share, by Product, 2022

Figure 04: Global Diagnostic Specialty Enzymes Market Revenue (US$ Mn), by Application, 2022

Figure 05: Global Diagnostic Specialty Enzymes Market Value Share, by Application, 2022

Figure 06: Global Diagnostic Specialty Enzymes Market Value Share, by Region, 2022

Figure 07: Global Diagnostic Specialty Enzymes Market Value (US$ Mn) Forecast, 2023–2031

Figure 08: Global Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031

Figure 09: Global Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031

Figure 10: Global Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031

Figure 11: Global Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031

Figure 12: Global Diagnostic Specialty Enzymes Market Value Share Analysis, by Region, 2022–2031

Figure 13: Global Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Region, 2023–2031

Figure 14: North America Diagnostic Specialty Enzymes Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 15: North America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Country, 2023–2031

Figure 16: North America Diagnostic Specialty Enzymes Market Value Share Analysis, by Country, 2022–2031

Figure 17: North America Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031

Figure 18: North America Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031

Figure 19: North America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031

Figure 20: North America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031

Figure 21: Europe Diagnostic Specialty Enzymes Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 22: Europe Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 23: Europe Diagnostic Specialty Enzymes Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 24: Europe Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031

Figure 25: Europe Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031

Figure 26: Europe Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031

Figure 27: Europe Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031

Figure 28: Asia Pacific Diagnostic Specialty Enzymes Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 29: Asia Pacific Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 30: Asia Pacific Diagnostic Specialty Enzymes Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 31: Asia Pacific Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031

Figure 32: Asia Pacific Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031

Figure 33: Asia Pacific Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031

Figure 34: Asia Pacific Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031

Figure 35: Latin America Diagnostic Specialty Enzymes Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 36: Latin America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 37: Latin America Diagnostic Specialty Enzymes Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 38: Latin America Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031

Figure 39: Latin America Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031

Figure 40: Latin America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031

Figure 41: Latin America Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031

Figure 42: Middle East & Africa Diagnostic Specialty Enzymes Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 43: Middle East & Africa Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 44: Middle East & Africa Diagnostic Specialty Enzymes Market Value Share Analysis, by Country/Sub-region, 2022–2031

Figure 45: Middle East & Africa Diagnostic Specialty Enzymes Market Value Share Analysis, by Product, 2022–2031

Figure 46: Middle East & Africa Diagnostic Specialty Enzymes Market Value Share Analysis, by Application, 2022–2031

Figure 47: Middle East & Africa Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Product, 2023–2031

Figure 48: Middle East & Africa Diagnostic Specialty Enzymes Market Attractiveness Analysis, by Application, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved